José Yélamos

16PUBLICATIONS
70CO-AUTHORS
Cancer cell biologyMolecular targetsLiquid biopsiesTumour immunologyProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 08, 2026
PARP2 deficiency impairs pancreatic cancer progression by promoting genomic instability and antitumor immunity.

|Dec 30, 2025
Targeting MARylation and DePARylation in Cancer Therapy: New Promising Therapeutic Opportunities.

Vanesa Cabeza-Fernández, Francisco Javier Ríos-Sola, David Martín-Oliva

|Mar 11, 2025
NEMO is essential for directing the kinases IKKα and ATM to the sites of DNA damage.

Josune Alonso-Marañón, Laura Solé, Daniel Álvarez-Villanueva

|Oct 22, 2024
Combined immunohistochemical profile CD10/LMO2/MYC is a useful tool to screen MYC rearrangements in aggressive large B-cell lymphomas.

Natalia Papaleo, Andrea Molina-Alvarez, Gustavo Tapia

|Jul 13, 2024
Chromogenic LMO2 mRNA ISH Expression Correlates with LMO2 Protein and Gene Expression and Captures Their Survival Impact in Diffuse Large B-Cell Lymphoma, NOS.

Natalia Papaleo, Andrea Molina-Alvarez, Ricard Onieva

|May 03, 2024
Specific and shared biological functions of PARP2 - is PARP2 really a lil' brother of PARP1?

Magdolna Szántó, José Yélamos, Péter Bai

Pageof 3

Frequent Collaborators

3 joint publications

Laura Llinàs-Mallol

3 joint publications

Dàlia Raïch-Regué

3 joint publications

Miguel López-Botet

3 joint publications

Carlos Martínez